HealthEquity (NASDAQ:HQY – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities researchers at Barrington Research in a report issued on Friday,Benzinga reports. They presently have a $112.00 price objective on the stock. Barrington Research’s price objective would suggest a potential upside of 19.19% from the company’s current price.
Other research analysts also recently issued research reports about the company. Mizuho initiated coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target for the company. JMP Securities boosted their target price on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. BTIG Research upped their price target on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Royal Bank of Canada lifted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Finally, The Goldman Sachs Group started coverage on HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 target price for the company. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $112.92.
Get Our Latest Stock Report on HQY
HealthEquity Stock Down 1.9 %
HealthEquity (NASDAQ:HQY – Get Free Report) last announced its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the firm earned $0.40 earnings per share. On average, equities research analysts expect that HealthEquity will post 2.32 earnings per share for the current fiscal year.
Insider Activity
In other news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 2.20% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On HealthEquity
Hedge funds have recently added to or reduced their stakes in the business. Ameritas Investment Partners Inc. increased its position in HealthEquity by 0.3% in the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company’s stock valued at $3,248,000 after acquiring an additional 88 shares during the period. Smartleaf Asset Management LLC grew its stake in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after purchasing an additional 98 shares during the last quarter. Louisiana State Employees Retirement System increased its holdings in HealthEquity by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock valued at $2,322,000 after purchasing an additional 100 shares during the period. Oregon Public Employees Retirement Fund raised its position in HealthEquity by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock worth $1,706,000 after purchasing an additional 100 shares during the last quarter. Finally, State of Michigan Retirement System lifted its holdings in HealthEquity by 0.5% during the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company’s stock worth $1,988,000 after buying an additional 100 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading
- Five stocks we like better than HealthEquity
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- D-Wave Quantum Stock Jumps on “Quantum Supremacy” News
- Should You Invest in Penny Stocks?
- How Taiwan Semiconductor’s U.S. Move Could Shift Chipmaking
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Crypto Crash Hits These 4 Blockchain Stocks—Is It Time to Buy?
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.